Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 3
2004 3
2005 4
2006 6
2007 2
2008 11
2009 15
2010 15
2011 15
2012 11
2013 21
2014 18
2015 28
2016 21
2017 13
2018 9
2019 6
2020 7
2021 6
2022 12
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.
Gasca-Salas C, Duff-Canning S, McArthur E, Armstrong MJ, Fox S, Meaney CA, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Marras C. Gasca-Salas C, et al. Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01;37(4):335-342. doi: 10.1097/WAD.0000000000000576. Epub 2023 Aug 22. Alzheimer Dis Assoc Disord. 2023. PMID: 37615480
Trial of Solanezumab in Preclinical Alzheimer's Disease.
Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team. Sperling RA, et al. N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17. N Engl J Med. 2023. PMID: 37458272 Free PMC article. Clinical Trial.
Natural cubic splines for the analysis of Alzheimer's clinical trials.
Donohue MC, Langford O, Insel PS, van Dyck CH, Petersen RC, Craft S, Sethuraman G, Raman R, Aisen PS; Alzheimer's Disease Neuroimaging Initiative. Donohue MC, et al. Pharm Stat. 2023 May-Jun;22(3):508-519. doi: 10.1002/pst.2285. Epub 2023 Jan 10. Pharm Stat. 2023. PMID: 36627206
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease.
Huang X, Li Y, Fowler C, Doecke JD, Lim YY, Drysdale C, Zhang V, Park K, Trounson B, Pertile K, Rumble R, Pickering JW, Rissman RA, Sarsoza F, Abdel-Latif S, Lin Y, Doré V, Villemagne V, Rowe CC, Fripp J, Martins R, Wiley JS, Maruff P, Mintzer JE, Masters CL, Gu BJ. Huang X, et al. Alzheimers Dement. 2023 May;19(5):2084-2094. doi: 10.1002/alz.12813. Epub 2022 Nov 9. Alzheimers Dement. 2023. PMID: 36349985 Free PMC article.
Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women.
Chung J, Das A, Sun X, Sobreira DR, Leung YY, Igartua C, Mozaffari S, Chou YF, Thiagalingam S, Mez J, Zhang X, Jun GR, Stein TD, Kunkle BW, Martin ER, Pericak-Vance MA, Mayeux R, Haines JL, Schellenberg GD, Nobrega MA, Lunetta KL, Pinto JM, Wang LS, Ober C, Farrer LA. Chung J, et al. Alzheimers Dement. 2022 Jun 30:10.1002/alz.12719. doi: 10.1002/alz.12719. Online ahead of print. Alzheimers Dement. 2022. PMID: 35770850 Free PMC article.
Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial.
Hakhu NR, Gillen DL, Grill JD; Alzheimer’s Disease Cooperative Study. Hakhu NR, et al. Alzheimer Dis Assoc Disord. 2022 Jul-Sep 01;36(3):192-199. doi: 10.1097/WAD.0000000000000506. Epub 2022 Apr 29. Alzheimer Dis Assoc Disord. 2022. PMID: 35482891 Free PMC article.
209 results